Company intelligence / Profile preview
Angelica Therapeutics
- Ownership
- Private
- Development stage
- Other
Overview
Angelica Therapeutics Inc. was an archived biotech company founded in 2006 in Emeryville, California. It focused on fusion toxin protein therapy and was funded solely by its founders and private investors.
- Modalities
- Fusion toxin protein therapy
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Angelica Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Angelica Therapeutics.